12.07.2015 Views

07/2013 - Državni zavod za intelektualno vlasništvo

07/2013 - Državni zavod za intelektualno vlasništvo

07/2013 - Državni zavod za intelektualno vlasništvo

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

2232 HR - Patenti - Hrvatski glasnik <strong>intelektualno</strong>g vlasništva 20, <strong>2013</strong>, 7, 2169 – 2293Broj objaveeuropskeprijave patenta(97)MKP(51)Datum kada je<strong>za</strong>htjev<strong>za</strong> proširenjeeuropskeprijave patentapovučenZahtjevobjavljenu HGIV-u br.Naziv izuma(54)Podnositeljeuropskeprijave patenta(71)EP 1845082 C<strong>07</strong>C 309/05 (2006.01)C<strong>07</strong>C 309/14 (2006.01)C<strong>07</strong>C 309/17 (2006.01)C<strong>07</strong>C 309/29 (2006.01)C<strong>07</strong>C 309/46 (2006.01)A61K 31/185 (2006.01)A61P 19/10 (2006.01)EP 2016388 * G01N 15/06 (2006.01)F23J 15/00 (2006.01)1.11.2012 11/20<strong>07</strong> New strontium salts ofsulphonic acids, preparationmethod and pharmaceuticalcompositions containing themLes Laboratoires Servier, 12, Place deLa Défense, 92415 CourbevoieCedex, FR1.5.<strong>2013</strong> 2/2009 PARTICLE MONITOR Scantech International Pty Ltd, 143Mooringe Avenue, Camden park,South Australia 5038, AUEP 2005468 * H01L 21/768 (2006.01) 3.1.<strong>2013</strong> 1/2009 IMPROVING CONTROL OFLOCALIZED AIR GAPFORMATION IN ANINTERCONNECT STACKEP 2001831 * C<strong>07</strong>C 211/27 (2006.01)C<strong>07</strong>C 233/78 (2006.01)C<strong>07</strong>D 295/12 (2006.01)A61K 31/166 (2006.01)A61K 31/40 (2006.01)A61K 31/445 (2006.01)A61P 25/28 (2006.01)1.11.2012 1/2009 COMPOUNDS WHICHINHIBIT THE GLYCINETRANSPORTER AND USESTHEREOFEP 2004820 * C12N 9/96 (2006.01) 14.5.<strong>2013</strong> 1/2009 LIQUID COMPOSITIONCOMPRISING AN ASPARTICPROTEASEEP 20<strong>07</strong>385 * A61K 31/47 (2006.01) 28.12.2012 2/2009 CARDIOVASCULARCOMPOSITION AND USETHE SAME FOR THETREATMENT OFALZHEIMERS DISEASEKoninklijke Philips Electronics, N.V.,Groenewoudseweg 1, 5621 BAEindhoven, NLCOMMISSARIAT A L'ENERGIEATOMIQUE, 31/33, Rue de laFédération, 75752 Paris 15eme, FRGLAXO GROUP LIMITED, GlaxoWellcome House, Berkeley Avenue,Greenford, Middlesex UB6 0NN, GBDSM IP Assets B.V., Het Overloon 1,6411 TE Heerlen, NLMount Sinai School of Medicine,Office of Industrial Liaison OneGustave L. Levy Place Box 1675,New York, NY 10029-6574, USEP 2012705 * A61F 2/00 (2006.01) 23.5.<strong>2013</strong> 2/2009 PHARMACEUTICALTransoral Pharmaceuticals, Inc., 161FORMULATIONS FOR Worcester Road, Suite 402,IONTOPHORETIC DRUG Framingham, MA 01701, USDELIVERYEP 2050142 * H01L 31/042 (2006.01) 3.1.<strong>2013</strong> 5/2009 SOLAR POWER PLANT Löseke&marx Maschinenbau -Anlagenbau Gmbh&co. Kg, Sander-Bruch-Strasse 115, 33104 Paderborn,DEEP 2057138 * C<strong>07</strong>D 311/74 (2006.01)C<strong>07</strong>D 335/06 (2006.01)C<strong>07</strong>D 4<strong>07</strong>/12 (2006.01)C<strong>07</strong>D 405/12 (2006.01)C<strong>07</strong>D 413/12 (2006.01)A61K 31/352 (2006.01)A61K 31/382 (2006.01)A61P 25/00 (2006.01)EP 2173854 * C12N 1/00 (2006.01)C12N 1/12 (2006.01)C12N 1/04 (2006.01)C12N 1/02 (2006.01)EP 2043606 * A61K 9/14 (2006.01)A61K 9/20 (2006.01)EP 2046357 * A61K 36/53 (2006.01)A61K 36/61 (2006.01)21.12.2012 6/2009 NOVEL CHROMENE ANDTHIOCHROMENECARBOXAMIDEDERIVATIVES, METHODSFOR PREPARING SAMEAND THERAPEUTICAPPLICATIONS OF SAME2.1.<strong>2013</strong> 4/2010 NOVELPSEUDOCHLOROCOCCUMSPECIES AND USESTHEREFOR3.1.<strong>2013</strong> 4/2009 NANOPARTICULATEKINASE INHIBITORFORMULATIONS28.12.2012 5/2009 ANTIOXIDANTCOMPOSITIONSCOMPRISING EXTRACTSOF MYRTLE ANDROSEMARYEP 2069337 * C<strong>07</strong>D 413/04 (2006.01) 4.6.<strong>2013</strong> 7/2009 SALTS OF 5 - ( L ( S ) -AMINO - 2 -HYDROXYETHYL ) -N- Ý ( 2,4 -DIFLUOROPHENYL) -METHYL¨- 2 - Ý 8 -METHOXY- 2 - (TRIFLUOROMETHYL) -5 - QUINOLINE¨- 4 -OXAZOLECARBOXAMIDEEP 2061347 * A23L 1/29 (2006.01)A23L 1/30 (2006.01)A61K 31/02 (2006.01)A61K 31/66 (2006.01)EP 2066328 * A61K 31/506 (2006.01)A61K 38/05 (2006.01)A61K 45/06 (2006.01)A61P 35/02 (2006.01)15.5.<strong>2013</strong> 6/2009 USE OF DPA(n-6) OILS ININFANT FORMULA28.5.<strong>2013</strong> 7/2009 COMBINATIONS OF CLASS-ISPECIFIC HISTONEDEACETYLASE INHIBITORSWITH PROTEASOMEINHIBITORSPierre Fabre Medicament, 45 PlaceAbel Gance, 92100 Boulogne-Billancourt, FRThe Arizona Board of Regents, ABody Corporate Acting on Behalf ofArizona State University, 699 S. MillAvenue, The Brickyard Suite 601,Room 691 AA, Tempe, AZ 85281, USElan Pharma International Limited,Monksland, Athlone CountyWestmeath, IENuraging Biotech S.r.l., LocalitaPiscinamanna, edif.5, 09010 Pula(CA), ITSCHERING CORPORATION, 2000Galloping Hill Road, Kenilworth, NewJersey <strong>07</strong>033-0530, USMartek Biosciences Corporation, 6480Dobbin Road, Columbia, MD 21045,USJANSSEN PHARMACEUTICA N.V.,Turnhoutsebaan 30, 2340 Beerse, BEISSN 1847-3024

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!